{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:17:08Z","timestamp":1761920228838,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:00:00Z","timestamp":1481241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Faculty of the University of Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10620-016-4370-4","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:29:10Z","timestamp":1481243350000},"page":"510-516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis"],"prefix":"10.1007","volume":"62","author":[{"given":"Andreas","family":"Wannhoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kilian","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Knierim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Flechtenmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl Heinz","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Stremmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel N.","family":"Gotthardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,9]]},"reference":[{"key":"4370_CR1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"R Chapman","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660\u2013678.","journal-title":"Hepatology"},{"key":"4370_CR2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"51","author":"European Association for the Study of the Liver","year":"2009","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237\u2013267.","journal-title":"J Hepatol"},{"key":"4370_CR3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","volume":"36","author":"A Bergquist","year":"2002","unstructured":"Bergquist A, Ekbom A, Olsson R, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002;36:321\u2013327.","journal-title":"J Hepatol"},{"key":"4370_CR4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","volume":"50","author":"MM Claessen","year":"2009","unstructured":"Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol. 2009;50:158\u2013164.","journal-title":"J Hepatol"},{"key":"4370_CR5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra K, Weersma RK, van Erpecum KJ, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58:2045\u20132055.","journal-title":"Hepatology"},{"key":"4370_CR6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","volume":"48","author":"P Charatcharoenwitthaya","year":"2008","unstructured":"Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology. 2008;48:1106\u20131117.","journal-title":"Hepatology"},{"key":"4370_CR7","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cgh.2015.07.014","volume":"13","author":"A Wannhoff","year":"2015","unstructured":"Wannhoff A, Rupp C, Friedrich K, et al. Inflammation but not biliary obstruction is associated with carbohydrate antigen 19-9 levels in patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2015;13:2372\u20132379.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4370_CR8","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0016-5085(95)90462-X","volume":"108","author":"JK Ramage","year":"1995","unstructured":"Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology. 1995;108:865\u2013869.","journal-title":"Gastroenterology"},{"key":"4370_CR9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/2050640615581577","volume":"4","author":"A Wannhoff","year":"2016","unstructured":"Wannhoff A, Folseraas T, Brune M, et al. A common genetic variant of fucosyltransferase 2 correlates with serum carcinoembryonic antigen levels and affects cancer screening in patients with primary sclerosing cholangitis. United Eur Gastroenterol J. 2016;4:84\u201391.","journal-title":"United Eur Gastroenterol J"},{"key":"4370_CR10","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jhep.2013.08.005","volume":"59","author":"A Wannhoff","year":"2013","unstructured":"Wannhoff A, Hov JR, Folseraas T, et al. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol. 2013;59:1278\u20131284.","journal-title":"J Hepatol"},{"key":"4370_CR11","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/jama.1976.03260440027017","volume":"235","author":"JC Alexander","year":"1976","unstructured":"Alexander JC, Silverman NA, Chretien PB. Effect of age and cigarette smoking on carcinoembryonic antigen levels. JAMA. 1976;235:1975\u20131979.","journal-title":"JAMA"},{"key":"4370_CR12","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/gut.14.11.880","volume":"14","author":"AH Rule","year":"1973","unstructured":"Rule AH, Goleski-Reilly C, Sachar DB, Vandevoorde J, Janowitz HD. Circulating carcinoembryonic antigen (CEA): relationship to clinical status of patients with inflammatory bowel disease. Gut. 1973;14:880\u2013884.","journal-title":"Gut"},{"key":"4370_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","volume":"36","author":"A Stiehl","year":"2002","unstructured":"Stiehl A, Rudolph G, Kloters-Plachky P, Sauer P, Walker S. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol. 2002;36:151\u2013156.","journal-title":"J Hepatol"},{"key":"4370_CR14","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","volume":"50","author":"C Levy","year":"2005","unstructured":"Levy C, Lymp J, Angulo P, Gores GJ, Larusso N, Lindor KD. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci. 2005;50:1734\u20131740.","journal-title":"Dig Dis Sci"},{"key":"4370_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","volume":"31","author":"N Chalasani","year":"2000","unstructured":"Chalasani N, Baluyut A, Ismail A, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology. 2000;31:7\u201311.","journal-title":"Hepatology"},{"key":"4370_CR16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mge.2002.125105","volume":"56","author":"E Siqueira","year":"2002","unstructured":"Siqueira E, Schoen RE, Silverman W, et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc. 2002;56:40\u201347.","journal-title":"Gastrointest Endosc"},{"key":"4370_CR17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1478-3231.1999.tb00083.x","volume":"19","author":"E Bjornsson","year":"1999","unstructured":"Bjornsson E, Kilander A, Olsson R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver. 1999;19:501\u2013508.","journal-title":"Liver"},{"key":"4370_CR18","first-page":"873","volume":"39","author":"C Rupp","year":"2014","unstructured":"Rupp C, Friedrich K, Folseraas T, et al. Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis Aliment. Pharmacol Ther. 2014;39:873\u2013882.","journal-title":"Pharmacol Ther"},{"key":"4370_CR19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000331074","volume":"29","author":"D Gotthardt","year":"2011","unstructured":"Gotthardt D, Chahoud F, Sauer P. Primary sclerosing cholangitis: diagnostic and therapeutic problems. Dig Dis. 2011;29:41\u201345.","journal-title":"Dig Dis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4370-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-016-4370-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4370-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:34:15Z","timestamp":1498354455000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-016-4370-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,9]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["4370"],"URL":"https:\/\/doi.org\/10.1007\/s10620-016-4370-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2016,12,9]]}}}